188 related articles for article (PubMed ID: 17982411)
1. Translation of pharmacogenetic knowledge into cancer therapeutics.
Yong WP; Innocenti F
Clin Adv Hematol Oncol; 2007 Sep; 5(9):698-706. PubMed ID: 17982411
[TBL] [Abstract][Full Text] [Related]
2. Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction?
Soh TI; Yong WP
Ann Acad Med Singap; 2011 Aug; 40(8):350-5. PubMed ID: 22065000
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
4. CYP450 pharmacogenetics for personalizing cancer therapy.
van Schaik RH
Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
[TBL] [Abstract][Full Text] [Related]
5. Individualized drug therapy.
Daly AK
Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
[TBL] [Abstract][Full Text] [Related]
6. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
7. FDA perspectives on pharmacogenetic testing.
Harper CC; Philip R; Robinowitz M; Gutman SI
Expert Rev Mol Diagn; 2005 Sep; 5(5):643-8. PubMed ID: 16149867
[TBL] [Abstract][Full Text] [Related]
8. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
Mladosievicova B; Carter A; Kristova V
Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology and pharmacogenetics of chemotherapeutic agents.
Dawood S; Leyland-Jones B
Cancer Invest; 2009 Jun; 27(5):482-8. PubMed ID: 19479485
[TBL] [Abstract][Full Text] [Related]
10. Establishing clinical utility of pharmacogenetic tests in the post-FDAAA era.
Evans BJ
Clin Pharmacol Ther; 2010 Dec; 88(6):749-51. PubMed ID: 21081943
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic application in personalized cancer treatment.
Kristyanto H; Utomo AR
Acta Med Indones; 2010 Apr; 42(2):109-15. PubMed ID: 20513938
[TBL] [Abstract][Full Text] [Related]
12. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics in clinical practice: considerations for testing.
Constable S; Johnson MR; Pirmohamed M
Expert Rev Mol Diagn; 2006 Mar; 6(2):193-205. PubMed ID: 16512779
[TBL] [Abstract][Full Text] [Related]
14. Ancillary risk information and pharmacogenetic tests: social and policy implications.
Henrikson NB; Burke W; Veenstra DL
Pharmacogenomics J; 2008 Apr; 8(2):85-9. PubMed ID: 17486108
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics and pharmacogenomics of anticancer agents.
Huang RS; Ratain MJ
CA Cancer J Clin; 2009; 59(1):42-55. PubMed ID: 19147868
[TBL] [Abstract][Full Text] [Related]
16. Adding pharmacogenetics information to drug labels: lessons learned.
Haga SB; Thummel KE; Burke W
Pharmacogenet Genomics; 2006 Dec; 16(12):847-54. PubMed ID: 17108808
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics: from discovery to patient care.
Shin J; Kayser SR; Langaee TY
Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin in cancer-related anemia.
Fenner MH; Ganser A
Curr Opin Oncol; 2008 Nov; 20(6):685-9. PubMed ID: 18841051
[TBL] [Abstract][Full Text] [Related]
19. Cancer pharmacogenetics.
Marsh S
Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
[TBL] [Abstract][Full Text] [Related]
20. Should pharmacogenomic studies be required for new drug approval?
Relling MV; Hoffman JM
Clin Pharmacol Ther; 2007 Mar; 81(3):425-8. PubMed ID: 17339872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
